GATA3 antibody is a valuable tool in both research and diagnostic pathology for detecting the presence of GATA3 protein, a transcription factor critical in cellular differentiation and tissue development. GATA3 belongs to the GATA family of zinc-finger transcription factors, which bind to DNA sequences containing the "GATA" motif to regulate gene expression. It plays essential roles in the development of various tissues, including the mammary glands, kidneys, and immune system, particularly in T-cell differentiation and Th2 cell polarization.
In diagnostic contexts, GATA3 is widely used as an immunohistochemical marker. It is highly expressed in hormone receptor-positive breast carcinomas and urothelial carcinomas, aiding in distinguishing these tumors from morphological mimics. Its expression is also observed in benign tissues like skin adnexa and salivary glands, necessitating careful interpretation. Beyond oncology, GATA3 is studied in immune disorders due to its role in immune cell regulation, linking it to allergies, asthma, and autoimmune diseases.
Commercially available GATA3 antibodies target specific epitopes, enabling applications in techniques like IHC, Western blot, and flow cytometry. However, staining intensity and specificity may vary depending on fixation methods and antibody clones. Ongoing research continues to explore its prognostic implications and therapeutic potential, particularly in cancers where GATA3 expression correlates with tumor behavior or treatment response.